Back to top

Analyst Blog

Perrigo Company’s (PRGO - Analyst Report) dominant position in the store brand over-the counter (OTC) drug market was further strengthened when it gained final approval from the U.S. Food and Drug Administration (FDA) to market its store brand version of Johnson & Johnson’s (JNJ - Analyst Report) Zyrtec allergy syrup (1mg/ml) for treating children aged two years and above. Perrigo intends to commence shipments of the offering, which is bubble gum flavored, during the upcoming cough/cold/flu season.

The children’s allergic Zyrtec syrup is part of the overall Zyrtec brand. Perrigo stated in its press release that the estimated annual sales of the drug are approximately $380 million. We remind investors that in Mar 2013, Perrigo made an important launch targeting the store brand market. The company launched its store brand version of an expectorant, Mucinex.
    
Another important launch at Perrigo targeted at the store brand market this year, was that of the OTC nicotine polacrilex mini lozenge, 2 mg (mint flavor) and 4 mg (mint flavor). We note that the product was approved by the FDA in Oct 2012 for reducing withdrawal symptoms like nicotine craving, associated with quitting smoking.

This is the first marketed mini lozenge product targeting the store brand market. The mint flavored mini lozenge can be compared to GlaxoSmithKline's (GSK - Analyst Report) Nicorette mini lozenge.

We note that Perrigo has a sustainable and diversified product portfolio. The company's strong position in the brand OTC pharmaceutical market and growing generics and active pharmaceuticals ingredient businesses are expected to drive growth in the coming quarters. We are also impressed by Perrigo's strong pipeline.

Perrigo currently carries a Zacks Rank #3 (Hold). Right now, Gilead Sciences Inc. (GILD - Analyst Report) looks attractive, with a Zacks Rank #1 (Strong Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
SYNAPTICS I… SYNA 78.11 +8.14%
CENTURY ALU… CENX 19.88 +5.74%
GREEN PLAIN… GPRE 39.41 +5.12%
PILGRIM'S P… PPC 28.82 +3.08%
THE PANTRY… PTRY 18.41 +2.79%